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Identification of a novel mutation in the cornea specific keratin 12
gene causing Meesmann`s corneal dystrophy in a German family
Ina Clausen, Gernot I.W. Duncker, Claudia Grünauer-Kloevekorn
Department of Ophthalmology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
Purpose: To report a novel missense mutation of the cornea specific keratin 12 (KRT12) gene in two generations of a
German family diagnosed with Meesmann`s corneal dystrophy.
Methods: Ophthalmologic examination of the proband and sequencing of keratin 3 (KRT3) and KRT12 of the proband
and three other family members were performed. Restriction enzyme analysis was used to confirm the detected mutation
in affected individuals of the family.
Results: Slit-lamp biomicroscopy of the proband revealed multiple intraepithelial microcysts comparable to a Meesmann
dystrophy phenotype. A novel heterozygous A→G transversion at the first nucleotide position of codon 129 (ATG>GTG,
M129V) in exon 1 of KRT12 was detected in the proband, her two affected sons but not in her unaffected husband or 50
control individuals.
Conclusions: We have identified a novel missense mutation within the highly conserved helix-initiation motif of KRT12
causing Meesmann`s corneal dystrophy in a German family.
The cornea represents the anterior surface of the eye and
must  maintain  its  structural  integrity  as  well  as  its
transparency to retain good vision. The outermost layer of the
cornea is presented by the corneal epithelium.
In 1939 the German ophthalmologists Meesmann and
Wilke described a dominantly inherited dystrophy affecting
the corneal epithelium in three families living in northern
Germany [1]. The 34 affected family members showed ocular
irritation, tearing, and glare. Slit lamp biomicroscopy revealed
myriads of microcystic epithelial opacities extending to the
corneal limbus. Twenty-six years after the initial report by
Meesmann and Wilke, Behnke and Thiel [2] published an
extensive study of the same three northern German families.
Kuwabara and Ciccarelli [3] were the first who examined the
ultrastructure of the cornea from patients with Meesmann`s
corneal dystrophy (MECD; OMIM 122100) in 1964. They
were followed by Fine et al. [4] in 1977 and Tremblay and
Dube [5] in 1982. The authors described the corneal epithelial
basement  membrane  as  thickened  with  an  intracellular
“peculiar  substance”  that  reacted  with  periodic  acid  and
Schiff`s reagent. This substance appeared to be derived from
the tonofilaments.
Keratins are a group of water-insoluble proteins that form
intermediate filaments in epithelial cells. They can be divided
into acidic and basic-neutral subfamilies according to their
relative charges, immunoreactivity, and sequence homologies
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to type I and II wool keratins, respectively. In vivo, a type I
keratin (acidic) pairs with a specific type II keratin (basic or
neutral) to form a heterodimer [6]. The structural integrity of
corneal  epithelial  cells  derives  mainly  from  its  unique
composition of the cytoskeletal intermediate filaments keratin
3  and  keratin  12,  whereby  disruption  of  a  single  keratin
polymer can compromise epithelial structure and function
[7].    Among   keratin    proteins    the    helix-initiation   and
helix-termination motifs are highly conserved and crucial for
intermediate filament heterodimerization.
A breakthrough approached in 1997 when McLean and
coworkers [8,9] examined two families from Northern Ireland
and German descendants of the family originally described by
Meesmann and Wilke. They were able to relate MECD to the
keratin cluster on chromosome 17 (17q12–21). In addition,
they performed molecular genetic studies by sequencing the
candidate genes keratin 3 (KRT3) and keratin 12 (KRT12) [8,
9].  Irvine  et  al.  [8]  postulated  that  dominant-negative
mutations in these keratins might be the cause of MECD.
Indeed, they found linkage of the disorder to the KRT12 locus
in Meesmann`s original German kindred. Furthermore, in the
two pedigrees from Northern Ireland, they found that the
disorder cosegregated with KRT12 in one pedigree and KRT3
in the other.
To our best knowledge three mutations in KRT3 and 19
mutations in KRT12 in patients showing MECD have been
identified  so  far  (Table  1)  [8-22].  In  KRT3  all  detected
mutations are located in the helix-termination motif (Figure
1), whereas in KRT12 mutations are found within the helix-
initiation and the helix-termination motif as well (Figure 2).
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954Here we report a novel heterozygous mutation within the
helix-initiation  motif  of  KRT12  causing  MECD  in  three
members of a German family.
METHODS
Subjects:  A  two  generation  family  with  three  affected
individuals was studied. The index patient (I/2), an 82-year-
old  woman,  was  examined  by  slit-lamp  biomicroscopy.
Peripheral  blood  samples  of  patient  I/2,  her  unaffected
husband  (I/1)  and  the  two  affected  sons  (II/1,  II/2)  were
obtained.  The  ophthalmological  history  of  the  proband`s
deceased parents was unknown. Fifty unrelated volunteers
were recruited to serve as controls. All subjects were treated
in accordance with the tenets of the Declaration of Helsinki
and signed a consent form.
DNA  collection,  polymerase  chain  reaction  amplification,
and sequencing: Genomic DNA was isolated from peripheral
blood leucocytes by standard procedures using the Invisorb
Spin  Blood  Maxi  Kit  (Invitek,  Berlin,  Germany).  Blood
samples (10 ml) treated with EDTA were processed following
the manufacturers instructions. Exons 1–9 of KRT3 and exons
1–8 of KRT12 were amplified using the primers shown in
Table 2. Each PCR reaction was performed in a volume of
50 µl containing 1 µM of forward and reverse primer, 0.5 U
of AmpliTaq Gold DNA Polymerase (Applied Biosystems
Inc.,  Foster  City,  CA),  1  µl  dNTP  mixture  (Applied
TABLE 1. REVIEW OF KNOWN MUTATIONS IN THE KERATIN 3 AND KERATIN 12 GENES CAUSING MECD.
Gene Exon Codon number Codon change Amino acid change References
KRT3 7 498 GAG-GTG Glu-Val [10]
  7 503 CGC-CCC Arg-Pro [11]
  7 509 GAG-AAG Glu-Lys [8]
KRT12 1 129 ATG-GTG Met-Val Current Report
  1 129 ATG-ACG Met-Thr [9]
  1 130 CAA-CCA Gln-Pro [12]
  1 132 CTT-CAT Leu-His [13]
  1 133 AAT-AAG Asn-Lys [14]
  1 135 AGA-ACA Arg-Thr [8]
  1 135 AGA-ATA Arg-Ile [15]
  1 135 AGA-AGC Arg-Ser [16]
  1 135 AGA-GGA Arg-Gly [15]
  1 137 GCT-CCT Ala-Pro [17]
  1 140 CTG-CGG Leu-Arg [15]
  1 143 GTG-CTG Val-Leu [8]
  1 143 GTG-TTG Val-Leu [18]
  6 1222ins27 400ins9 [16]
  6 426 ATT-AGT Ile-Ser [19]
  6 426 ATT-GTT Ile-Val [20]
  6 429 TAT-GAC Tyr-Asp [15]
  6 429 TAT-TGT Tyr-Cys [11]
  6 430 CGC-CCC Arg-Pro [21]
  6 433 CTG-CGG Leu-Arg [22]
Figure 1. Scheme of the KRT3 structure. The localizations of the known point mutations within the helix-termination motif are indicated.
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955Biosystems), 5 µl of 10× PCR buffer (Applied Biosystems)
and 100 ng of human genomic DNA. Amplification reactions
were performed under the following conditions: 5 min of
denaturation at 96 °C followed by 35 cycles of denaturation
at 96 °C for 30 s, annealing at 60–66 °C for 30 s, extension at
72 °C for 45 s, and a further extension step at 72 °C for 5 min.
For direct sequencing, amplified DNA was purified using the
QIAquick  PCR  purification  kit  (Qiagen  GmbH,  Hilden,
Germany), cycle sequenced with BigDye Terminator v3.1
Cycle  Sequencing  kit  (Perkin  Elmer,  Waltham,  MA)  and
directly sequenced using an automatic sequencer (ABI 3100
Genetic Analyzer C; Applied Biosystems).
Mutation confirmation: The mutation M129V generated a
HpyCH4III  (New  England  Biolabs  GmbH,  Frankfurt,
Germany)  restriction  enzyme  site  in  exon  1b  of  KRT12.
Therefore, PCR products of all four family members (three
affected and one unaffected individual) as well as 50 unrelated
control subjects were submitted to restriction digestion under
the following conditions. A reaction mixture containing 10 µl
PCR  product,  5  µl  enzyme,  25  µl  NEBuffer  4  (50  mM
potassium-acetate, 20 mM Tris-acetate, 10 mM magnesium-
Figure 2. Scheme of the KRT12 structure. The localizations of the known point mutations within the helix-initiation and the helix-termination
motif are indicated.
TABLE 2. PRIMERS FOR POLYMERASE CHAIN REACTION DIRECT SEQUENCING OF KRT3 AND KRT12.
Exon Forward primer sequence (5`→3′) Reverse primer sequence (5′→3′) Size (bp)
Keratin 3
 
1 TGCACAGGTCTTCATTTCCCATCC TCCTCAACCCTGGATATCTTCCCA 887
2 AGTGTTGCCTGATGTTGCTTCCTG ACCATGCTTGGAGAAGGAAGGTGA 439
3 ATGGAGGGAGGGAAGAGATGAACT ATTGCTCCAAAGGCCTGAACTTGG 275
4 GCTCTTTCTTGCTGCAGTTGTGGT GCACCAGCCTCAAATCTGGAAACA 238
5 AGTGAACAAGCTCCCTCTGTGTTG TGAAACCTCCAGTGGATCCCGTAA 235
6 AAGGTTTGGTGGGTGATGTTGGAG ATTTGTGGAGATACTGCCCTGTGG 345
7 AATCCATTGCATGTCAGGAAGGGC TATCTGGCCCTTGGCCTATGACTT 354
8 TGTTGGTGATGTGCTTTGTGACGG AAGCCAATCACTTCCCTCTCCTCT 228
9 ACAATAACATAGCAGCTGGCCTGG AATACTCAGAGGCCCGGAGTGAAA 756
Keratin 12  
1a GGATCCAATTTTGAGTGGAGA ACCTAGAGAGCCACCTCCTGGGCT 459
1b AGCCCAGGAGGTGGCTCTCTA AGTACAGCTAAATTGGAAAAT 369
2 TAGTCTTTTAGGGCTTCAATC AGGCAGGACAGTAGGACAGA 194
3 GCAAGAAATAGCCCTGAAGA TTTTGGGTCTGGGAGAAA 297
4 GGCCCAAGAGGACAAAAGTA GCAGGCCTTTCTGTGAATGT 290
5 AGAAAGGCCTGCGAA AAAAGAGGAGGGTAGCCAAC 278
6 GTCCCCTCCATCGTTATTTC CTATTTCTGCTGCCCACTCT 330
7 TCCATTAAAAGCCAGGTTGT GGTCTTACAGGTTTTGCATT 198
8 GCCTACATTAAACAACCAGT TGACCAAAATGACTTGTGACTG 370
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956acetate,  1  mM  dithiothreitol;  New  England  Biolabs),  and
170 µl H2O was incubated overnight at 37 °C. In the presence
of the heterozygous M129V mutation, HpyCH4III digestion
resulted in fragments of 293 bp and 76 bp with the additional
undigested 369 bp PCR product. The digested products were
separated and visualized on a 2% agarose gel stained with
ethidium bromide. Digestion analysis was additionally used
to  screen  fifty  healthy  control  subjects  for  the  M129V
mutation.
RESULTS
Clinical exam: Slit lamp examination of patient I/2 revealed
multiple microcysts within the corneal epithelium of both eyes
with highest density in the center of the cornea (Figure 3). The
proband had recurrent corneal erosions, blurred vision, and
tearing. Visual acuity was highly reduced (OD finger count,
OS 5/20) predominantly due to high myopia with myopic
macular  degeneration.  Additionally,  the  patient  was
pseudophacic with posterior chamber lenses after cataract
surgery. Ocular tension was within normal range.
KRT3 sequence analysis: The sequence analysis of all nine
exons  of  KRT3  revealed  no  mutations  in  the  four  family
members.
KRT12  sequence  analysis:  Direct  forward  and  backward
sequencing of exon 1b of KRT12 disclosed the heterozygous
409A>G transversion at the first nucleotide position of codon
129 (ATG>GTG) in the proband I/2 (Figure 4) and her two
affected sons (II/1, II/2). This is predicted to substitute a valine
residue for methionine (M129V, NM_000223). This missense
mutation  was  absent  in  the  unaffected  husband  (I/1).
Additionally, the proband and her sons harbored the single-
nucleotide polymorphism (SNP) 43C>T (Figure 5), resulting
in an amino acid change in codon 15 from proline to serine
(P15S, NM_000223). Further sequence analysis of exons 2–
8 did not show any alterations.
Mutation  confirmation:  Restriction  enzyme  analysis
employing HpyCH4III resulted in digested fragments of 76
bp and 293 bp in the proband (I/2) and her two affected sons
(II/1, II/2) as shown in Figure 6. Since the found mutation is
heterozygous, the undigested wild type fragment of 369 bp is
also seen. Exclusively undigested wild type DNA was seen in
the  unaffected  husband  (I/1)  and  in  fifty  healthy  control
individuals (data not shown).
DISCUSSION
All known mutations in the cornea specific genes KRT3 and
KRT12 are responsible for the development of Meesmann`s
corneal dystrophy, an autosomal dominant disorder of the
corneal epithelium. Until the present study, three mutations
have been reported in KRT3 and 19 in KRT12, including a 27-
nucleotide  long  insertion  in  exon  6.  All  mutations  are
summarized in Table 1. It is noteworthy, that the majority of
Figure  3.  Slit  lamp  photography  of
patient  I/2.  The  corneal  epithelium
showed bilateral myriads of fine cysts
predominantly  in  the  center  of  the
cornea (A=right eye, B=left eye).
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957the KRT12 mutations are localized within the region encoding
the helix-initiation motif. In contrast, the known mutations of
KRT3 are exclusively within the helix-termination motif. In
keratin proteins, the helix-initiation and –termination motifs
are highly conserved regions playing an important role in
normal filament assembly [23].
With the predicted amino acid substitution M129V we
revealed the third mutation of KRT12 in a German family.
Previously,  Irvine  and  coworkers  [8]  identified  the  point
mutation  R135T  in  descendants  of  the  German  kindred
originally described by Meesmann and Wilke [1]. In 2000,
Corden et al. [12] reported a Q130P substitution in a southern
German family.
Another  nucleotide  exchange  within  the  same  codon
(M129T) predicting the substitution of the methionine (ATG)
residue by threonine (ACG) was described independently by
Figure  4.  Chromatogram  of  the
heterozygous  409G>A  mutation  at
codon  129  in  the  keratin  12  gene  of
patient I/2.
Figure 5. Chromatogram of the single
point  polymorphism  67C>T  in  the
keratin 12 gene of patient I/2.
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958Cordon et al. [9] and Nichini et al. [19] in American families.
It is unknown whether these individuals are related.
Our index patient, an 82-year-old female, had a rather
severe  case  of  MECD  with  photophobia,  tearing,  and
recurrent painful corneal erosions since adulthood. Visual
acuity  was  highly  reduced  due  to  myopic  macular
degeneration. Additionally, the proband and her affected sons
harboured  the  SNP  67C>T  predicting  the  amino  acid
substitution P15S. This SNP has been previously described by
Nielsen et al. [18] in an asymptomatic Danish family. The
allele frequency in healthy probands was calculated to be
29%. Since the affected family members described by Nielsen
et al. [18] presented an asymptomatic form of MECD, it seems
unlikely, that the additional SNP should be responsible for the
severity of symptoms in our patient.
Still, it seems cryptic why certain mutations lead to a
more or less severe phenotype. Severe cases of MECD have
been reported due to mutations within the helix initiation motif
[12,14]  as  well  as  the  helix  termination  motif  [21].
Furthermore, the quality of the amino acid change seems not
to elucidate the genotype-phenotype correlation. The V143L
substitution in an asymptomatic Danish family means the
exchange of two neutral aliphatic amino acids [18]. However,
in our patient the aliphatic neutral methionine is replaced by
another aliphatic and neutral amino acid (valine) as well.
Moreover, mutations in KRT3 cause a MECD phenotype
indistinguishable  from  KRT12  mutations.  Kao  et  al.  [7]
demonstrated  the  importance  of  functional  KRT3/KRT12
heterodimers for corneal stability in a KRT12 knockout mouse
model. Any modification that results in an impairment of the
heterodimerization process will lead to corneal fragility. This
could  explain  why  mutations  in  any  member  of  the
heterodimer lead to almost identical phenotypes. Therefore,
other  individual  factors  may  contribute  to  the  MECD
phenotype.
The present study adds another novel mutation to the
collection  of  mutations  causing  Meesmann`s  corneal
dystrophy.
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